Jump to content
  • Sign Up
×
×
  • Create New...
New feature: 1 Vote = 0.10€ for server Owner!

Novo Nordisk shares fall after CagriSema weight-loss drug trial result

Pelican Press

By Pelican Press,
in World News

 Share

Recommended Posts

  • Diamond Member
Pelican Press Warlord

Pelican Press 0

Posted
  • Diamond Member
Posted

This is the hidden content, please

Novo Nordisk shares fall after CagriSema weight-loss drug trial result

Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background.

Nurphoto | Nurphoto | Getty Images

Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop 15.7% of their weight after 68 weeks.

The company’s stock was down 5.52% at 11:10 a.m. London time.

This breaking news story is being updated.



This is the hidden content, please

#Novo #Nordisk #shares #fall #CagriSema #weightloss #drug #trial #result

This is the hidden content, please

This is the hidden content, please

0

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Unfortunately, your content contains terms that we do not allow. Please edit your content to remove the highlighted words below.
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
 Share
Go to topic listing

  • Vote for the server

    To vote for this server you must login.

    Jim Carrey Flirting GIF

  • Recently Browsing   0 members

    • No registered users viewing this page.

Important Information

Privacy Notice: We utilize cookies to optimize your browsing experience and analyze website traffic. By consenting, you acknowledge and agree to our Cookie Policy, ensuring your privacy preferences are respected.

  I accept